Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan for Reverse Remodelling After Aortic Valve Replacement
NCT00294775Phase 3Unknown
- Sponsor
- University Hospital Odense
- Start
- Feb 2006
- Primary completion
- Jan 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of candesartan in left ventricular hypertrophy (LVH), sponsored by University Hospital Odense. Status: unknown.
02
Drugs
candesartan
03
Conditions
left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT00294775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294775.